Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I

Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I

Tyrosinemia type I (HTI) is treated with nitisinone, a tyrosine (Tyr) and phenylalanine (Phe)-restricted diet, and supplemented with a Tyr/Phe-free protein substitute (PS). Casein glycomacropeptide (CGMP), a bioactive peptide, is an alternative protein source to traditional amino acids (L-AA). CGMP...

Full description

Bibliographic Details
Main Authors: Anne Daly, Sharon Evans, Alex Pinto, Catherine Ashmore, Anita MacDonald
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Nutrients
Subjects:
tyrosinemia type 1
protein substitute
amino acids
glycomacropeptide
Online Access:https://www.mdpi.com/2072-6643/13/9/3224

Internet

https://www.mdpi.com/2072-6643/13/9/3224

Similar Items